Article
[Effectiveness of lamivudine in the treatment of chronic HBeAg-negative viral hepatitis B: results of continuous therapy for 18 months].
Klinicheskaia meditsina - 1 Jan 2003
Tsodikov G V, Isakov V A, Seliverstova T R, Bogomolov P O, Shakhovskiĭ Iu K, Pavlova T V, Mironova O S, Banina V B, Kazantseva I A, Gushchin A E
Abstract excerpt
The efficacy of monotherapy with one of the analogues of synthetic nucleosides (lamivudine) was studied in 22 patients with chronic viral hepatitis B (CVHB). The specific feature of the selected group was that there was no serum HBeAg, which is usually regarded as a sign of viral mutation. The time course of changes in the activity of blood and hepatic inflammatory processes and viral replication were studied at...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.